• Je něco špatně v tomto záznamu ?

Pulmonary perfusion in long-term survivors of COVID-19-related severe acute respiratory distress syndrome treated by extracorporeal membrane oxygenation

L. Miksová, V. Dytrych, V. Ptáčník, M. Balík, A. Linhart, J. Bělohlávek, P. Jansa

. 2024 ; 14 (3) : e12431. [pub] 20240825

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24017971

COVID-19 associates with a hypercoagulant state and an increased risk for venous thromboembolic events (VTEs). Whether severe COVID-19 infection requiring extracorporeal membrane oxygenation (ECMO) support might lead to chronic pulmonary perfusion abnormalities and chronic thromboembolic pulmonary disease/hypertension remains unclear. The purpose of this study was to evaluate chronic pulmonary perfusion abnormalities in long-term survivors of COVID-19-related severe acute respiratory distress syndrome (ARDS) treated by ECMO at our institution. Pulmonary perfusion was examined by ventilation/perfusion (V/Q) single-photon emission computed tomography or V/Q planar scintigraphy at least 3 months after ECMO explantation, comorbidities and incidence of thromboembolic events were recorded as well. Of 172 COVID-19 patients treated by ECMO for severe COVID-19 pneumonia between March 2020 and November 2021, only 80 were successfully weaned from ECMO. Of those, 37 patients were enrolled into the present analysis (27% female, mean age 52 years). Median duration of ECMO support was 12 days. In 24 (65%) patients VTE was recorded in the acute phase (23 patients developed ECMO cannula-related deep vein thrombosis, 5 of them had also a pulmonary embolism, and one thrombus was associated with a central catheter). The median duration between ECMO explantation and assessment of pulmonary perfusion was 420 days. No segmental or larger mismatched perfusion defects were then detected in any patient. In conclusion, in long-term survivors of COVID-19-related ARDS treated by ECMO, no persistent pulmonary perfusion abnormalities were detected although VTE was common.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24017971
003      
CZ-PrNML
005      
20241016082006.0
007      
ta
008      
241008s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/pul2.12431 $2 doi
035    __
$a (PubMed)39188535
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Miksová, Lucie $u Clinical Department of Cardiology and Angiology of the 2nd Department of Medicine General University Hospital in Prague Prague Czech Republic $1 https://orcid.org/0009000750432281
245    10
$a Pulmonary perfusion in long-term survivors of COVID-19-related severe acute respiratory distress syndrome treated by extracorporeal membrane oxygenation / $c L. Miksová, V. Dytrych, V. Ptáčník, M. Balík, A. Linhart, J. Bělohlávek, P. Jansa
520    9_
$a COVID-19 associates with a hypercoagulant state and an increased risk for venous thromboembolic events (VTEs). Whether severe COVID-19 infection requiring extracorporeal membrane oxygenation (ECMO) support might lead to chronic pulmonary perfusion abnormalities and chronic thromboembolic pulmonary disease/hypertension remains unclear. The purpose of this study was to evaluate chronic pulmonary perfusion abnormalities in long-term survivors of COVID-19-related severe acute respiratory distress syndrome (ARDS) treated by ECMO at our institution. Pulmonary perfusion was examined by ventilation/perfusion (V/Q) single-photon emission computed tomography or V/Q planar scintigraphy at least 3 months after ECMO explantation, comorbidities and incidence of thromboembolic events were recorded as well. Of 172 COVID-19 patients treated by ECMO for severe COVID-19 pneumonia between March 2020 and November 2021, only 80 were successfully weaned from ECMO. Of those, 37 patients were enrolled into the present analysis (27% female, mean age 52 years). Median duration of ECMO support was 12 days. In 24 (65%) patients VTE was recorded in the acute phase (23 patients developed ECMO cannula-related deep vein thrombosis, 5 of them had also a pulmonary embolism, and one thrombus was associated with a central catheter). The median duration between ECMO explantation and assessment of pulmonary perfusion was 420 days. No segmental or larger mismatched perfusion defects were then detected in any patient. In conclusion, in long-term survivors of COVID-19-related ARDS treated by ECMO, no persistent pulmonary perfusion abnormalities were detected although VTE was common.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dytrych, Vladimír $u Clinical Department of Cardiology and Angiology of the 2nd Department of Medicine General University Hospital in Prague Prague Czech Republic
700    1_
$a Ptáčník, Václav $u Institute of Nuclear Medicine of the 1st Faculty of Medicine and General University Hospital in Prague Prague Czech Republic
700    1_
$a Balík, Martin $u Department of Anesthesiology and Intensive Care of the 1st Faculty of Medicine and General University Hospital in Prague Prague Czech Republic $1 https://orcid.org/0000000318642143 $7 xx0075661
700    1_
$a Linhart, Aleš $u Clinical Department of Cardiology and Angiology of the 2nd Department of Medicine General University Hospital in Prague Prague Czech Republic
700    1_
$a Bělohlávek, Jan $u Clinical Department of Cardiology and Angiology of the 2nd Department of Medicine General University Hospital in Prague Prague Czech Republic
700    1_
$a Jansa, Pavel $u Clinical Department of Cardiology and Angiology of the 2nd Department of Medicine General University Hospital in Prague Prague Czech Republic
773    0_
$w MED00200184 $t Pulmonary circulation $x 2045-8932 $g Roč. 14, č. 3 (2024), s. e12431
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39188535 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241008 $b ABA008
991    __
$a 20241016082001 $b ABA008
999    __
$a ok $b bmc $g 2196423 $s 1229922
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 14 $c 3 $d e12431 $e 20240825 $i 2045-8932 $m Pulmonary circulation $n Pulm Circ $x MED00200184
LZP    __
$a Pubmed-20241008

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...